Alex Q. Hoogkamer

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Isabel S. Jerchel, Alex Q. Hoogkamer, Ingrid M. Ariës et al. · Leukemia · 2017 · 116 citations · Full text

Medicine, Hematology, Oncology +17

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Elisabeth M. P. Steeghs, Judith M. Boer, Alex Q. Hoogkamer et al. · Scientific Reports · 2019 · 54 citations · Full text

Life Sciences, Genetics, Oncology +17

<i>JAK2</i> aberrations in childhood B-cell precursor acute lymphoblastic leukemia

Elisabeth M. P. Steeghs, Isabel S. Jerchel, Willemieke de Goffau-Nobel et al. · Oncotarget · 2017 · 48 citations · Full text

Medicine, Hematology, Oncology +15

RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Isabel S. Jerchel, Alex Q. Hoogkamer, Ingrid M. Ariës et al. · Blood · 2016 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17

High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia

Elisabeth M. P. Steeghs, Marjolein Bakker, Alex Q. Hoogkamer et al. · Scientific Reports · 2018 · 19 citations · Full text

Life Sciences, Molecular Biology, Oncology +17